"Maybe they could answer the question, is the 95th biosimilar switching trial likely to show something different to the previous 94?" asks UK oncologist Dr Paul Cornes. …
Latest Video
New Stories
-
EBOS reports earnings growth as it prepares for Chemist Warehouse
February 21, 2019 - - Latest News -
MA: Where are the service standards and KPIs?
February 21, 2019 - - Latest News -
MA appoints two new board members
February 21, 2019 - - Latest News -
A nine month post-PBAC process?
February 21, 2019 - - Latest News -
What next for payment reform?
February 20, 2019 - - Latest News -
New report calls for greater focus on secondary CV events
February 20, 2019 - - Latest News -
Fee 'crunch' for smaller companies and patient populations
February 20, 2019 - - Latest News